In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

PCR London Valves 2012

2012 edition of PCR London Valves was the 3rd course since its inception by Martyn Thomas, Simon Redwood and colleagues in 2009 and was hosted in the Olympic city of London from 30 September through 2 October 2012.



The official meeting of the EAPCI and the PCR family

The meeting has become the official meeting of the EAPCI and the PCR family, which anchors it within the well-established European culture of Invasive Cardiology with a major focus on education.

The Course moved to a new venue, The Queen Elizabeth Conference Centre, just opposite Westminster Abbey and near to the Houses of Parliament and “Big Ben”.

This was triggered by the need for more capacity due to the growing number of participants and presentations.

Highlights of this years' course

Record of participation

There were a record breaking number of participants with a total of 1,303 participants representing a 23% increase in attendance compared with 2011.

Geographic representation

Importantly, the geographic representation was global and included numerous delegates from North and South America, Asia-Pacific, Middle East and Africa beyond those attending from Europe.

A multidisciplinary meeting

The number of participants registered as Heart Teams further increased to 312 delegates reinforcing the multidisciplinary character of the meeting.
In addition, the course welcomed any specialty with interest in valvular heart disease including invasive cardiologists, general cardiologists, cardiac surgeons, nurse technicians, anesthesiologists, imaging specialists and vascular surgeons.

Pratical sessions and novel innovations

At the core of the course were practical sessions including complications forum, clinical tips and tricks, and Learn-the-Technique modules. In addition, there were sessions on novel innovations and devices, abstract presentations, multidisciplinary heart team meetings, and health economics.  There were 3 live centers transmitting a total of 12 cases from St Thomas Hospital in London, Bern University Hospital, Switzerland, and Hospital Clinical San Carlos in Madrid with a wide range of clinical and procedural challenges ranging from paravalvular leak closure to transcatheter “valve in valve” procedures including the tricuspid and mitral valve.

92 abstract submissions

From a total of 92 abstract submissions, 39 abstracts were accepted for oral presentation and subsequent publication in the EuroIntervention Valves supplement. In addition, there were 47 E-abstracts with 251 views on-site. There were 74 clinical case submissions and 35 were accepted for oral presentation.

EuroIntervention supplement

All attendees were provided with a copy of a dedicated EuroIntervention supplement with focus on transcatheter heart valve interventions including reviews on the issue of aortic regurgitation after TAVI, cerebrovascular accidents complicating TAVI, novel TAVI devices, percutaneous mitral valve interventions as well as all abstracts presented at the Course.

10th anniversary of the first TAVI

It was also time to commemorate the 10th anniversary of the first Transcatheter Aortic Valve Implantation (TAVI) performed by Alain Cribier in 2002. During a Monday evening gathering, pioneers involved from the very first moment including Henning Anderson, Alain Cribier, Jean-Claude Laborde, Michael Mack and Eberhard Grube were interviewed and shared their personal experience.

The spirit of PCR London Valves 2012 was that of a practical interactive meeting of “Heart Teams” dedicated to sharing experience with the goal to improve outcomes for patients with valvular heart disease.

With this in mind, we are looking forward to prepare yet another edition in 2013.

Access the scientific content.